- Home
- WRLD vs QURE Comparison
WRLD vs QURE Comparison
Compare WRLD & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRLD | QURE |
|---|---|---|
| Founded | 1962 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 660.6M | 663.4M |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WRLD | QURE |
|---|---|---|
| Price | $138.62 | $15.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $45.42 |
| AVG Volume (30 Days) | 113.4K | ★ 4.5M |
| Earning Date | 04-27-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $564,841,465.00 | $13,107,000.00 |
| Revenue This Year | N/A | $126.14 |
| Revenue Next Year | $6.51 | $395.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $104.99 | $7.76 |
| 52 Week High | $185.48 | $71.50 |
Technical Indicators
Market Signals| Indicator | WRLD | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 55.39 | 43.32 |
| Support Level | $138.35 | $13.29 |
| Resistance Level | $140.69 | $16.99 |
| Average True Range (ATR) | 7.29 | 1.96 |
| MACD | -0.20 | 0.28 |
| Stochastic Oscillator | 53.93 | 55.56 |
Price Performance
Historical ComparisonAbout WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.